Longeveron Inc.

The momentum for this stock is not very good. Longeveron Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Longeveron Inc..

News

Maxim Group Lowers Longeveron (NASDAQ:LGVN) Price Target to $6.00

Zolmax Longeveron (NASDAQ:LGVN - Get Free Report) had its target price reduced by analysts at Maxim Group from $15.00 to $6.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm...\n more…

Longeveron price target lowered by $9 at Maxim, here's why

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Globe Newswire MIAMI, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic...\n more…

HC Wainwright Weighs in on Longeveron Inc.'s Q3 2024 Earnings (NASDAQ:LGVN)

Ticker Report Longeveron Inc. (NASDAQ:LGVN - Free Report) - Equities research analysts at HC Wainwright upped their Q3 2024 earnings estimates for Longeveron in a report issued on Thursday, August 15th. HC...\n more…

Longeveron Second Quarter 2024 Earnings: Misses Expectations

Simply Wall St Longeveron ( NASDAQ:LGVN ) Second Quarter 2024 Results Key Financial Results Net loss: US$11.9m (loss widened by 112...\n more…

Longeveron (NASDAQ:LGVN) Stock Rating Reaffirmed by HC Wainwright

Ticker Report Longeveron (NASDAQ:LGVN - Get Free Report)s stock had its "buy" rating reiterated by equities research analysts at HC Wainwright in a report released on Thursday, Benzinga reports. They...\n more…